Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease

NCT04902703 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Sargramostim
DRUG: Saline - placebo comparator

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]
[object Object]